Baxter | 合法醫療器材資訊網

2012年2月14日—...companyhascompleteditsplannedacquisitionofSynovisLifeTechnologies,...Today,BaxterisaddingtheSynovissofttissuerepairand ...

DEERFIELD, Ill., February 14, 2012 - Baxter International Inc. (NYSE:BAX) announced today that the company has completed its planned acquisition of Synovis Life Technologies, Inc. (NASDAQ: SYNO), following approval of the transaction by Synovis shareholders.  The acquisition expands Baxters regenerative medicine and BioSurgery franchise by adding biological and mechanical products from Synovis used for soft tissue repair and microsurgery in a variety of surgical procedures.

"The acquisition enhances Baxters ability to offer a broad range of tools used to repair and reconstruct soft tissue damaged by disease or injury, as well as specific tools used in a variety of microsurgical procedures," said Ludwig Hantson, president of Baxters BioScience business. "We look forward to welcoming the Synovis employees and organization into Baxter as we begin the business integration process."

Bax...